AlphaStocks
4.0
Weak

Cytokinetics Inc (CYTK)

As of Sep 19, 2026, Cytokinetics Inc (CYTK) scores 4.0/10 on AlphaStocks' five-model composite, #136 of 168 Health Care stocks.

Health Care / Biotechnology

S&P MidCap 400

$68.74

Below average on several measures. Research carefully.

Weak

Score based on 4 of 5 models — moderate confidence

Data as of Sep 19, 2026

#136out of 168 in Health Care

Is CYTOKINETICS INC a Good Investment in 2026?

CYTOKINETICS INC (CYTK) scores 4.0 out of 10 on AlphaStocks' composite model, earning a Weak rating. The Graham model is the most favorable, rating CYTOKINETICS INC as Neutral. However, the Greenblatt Magic Formula model rates it Caution — Earnings yield -349.4% · ROC -77%. CYTOKINETICS INC ranks #136 out of 168 stocks in the Health Care sector.

This summary is algorithmically generated and is not financial advice.

Key Metrics

ROE23.1Market Cap8B

Valuation

Currently unprofitable — fair value estimate not available.

Fair value estimate not available for this stock.

5-Model Analysis

Each model evaluates this stock from a different angle. Combined, they form the composite score above.

Piotroski

Caution

2/9

Buffett

Caution

Business quality & competitive moat

Graham

Neutral

Price vs intrinsic value

Lynch

Limited Data

Growth rate vs price (PEG)

Greenblatt

Caution

Earnings yield -349.4% · ROC -77%

Frequently Asked Questions

Is CYTOKINETICS INC (CYTK) a good investment?
As of Sep 19, 2026, Cytokinetics Inc (CYTK) scores 4.0/10 on AlphaStocks' five-model composite, #136 of 168 Health Care stocks. That score is below average, suggesting caution. Currently unprofitable — fair value estimate not available.
What is CYTOKINETICS INC's Piotroski F-Score?
CYTOKINETICS INC's Piotroski F-Score status is Caution. The raw score is 2/9. The Piotroski F-Score evaluates financial health using 9 fundamental signals including profitability, leverage, and operating efficiency.
Is CYTK overvalued or undervalued?
A precise fair value estimate is not available for CYTK. Currently unprofitable — fair value estimate not available.
How does CYTK compare to other Health Care stocks?
CYTOKINETICS INC ranks #136 out of 168 stocks in the Health Care sector, placing it in the top 81% of its sector by composite score. There are higher-ranked alternatives in this sector worth exploring.
What do investment models say about CYTK?
AlphaStocks evaluates CYTK using five proven investment models. Piotroski: Caution; Buffett: Caution; Graham: Neutral; Greenblatt Magic Formula: Caution. These models are combined into a single composite score of 4.0/10.

Similar Stocks

ABBVINCYHRMY

Compare CYTK with

ABBV vs CYTKCYTK vs INCYCYTK vs HRMY

Scores are algorithm-generated research tools, not investment recommendations. Past performance does not guarantee future results. Always do your own due diligence. Full disclaimer